The assessment of ovarian reserve in premenopausal women requiring anticancer gonadotoxic therapy can help clinicians address some challenging issues, including the probability of future pregnancies after the end of treatment. Anti-Müllerian hormone (AMH) and age can reliably estimate ovarian reserve. A limited number of studies have evaluated AMH and age as predictors of residual ovarian reserve following cytotoxic chemotherapy in breast cancer patients.
Barnabei, A., Strigari, L., Marchetti, P., Sini, V., De Vecchis, L., Corsello, S. M., Torino, F., Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram, <<THE ONCOLOGIST>>, 2015; 20 (10): 1111-1118. [doi:10.1634/theoncologist.2015-0183] [http://hdl.handle.net/10807/70223]
Autori: | |
Titolo: | Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1634/theoncologist.2015-0183 |
Data di pubblicazione: | 2015 |
Abstract: | The assessment of ovarian reserve in premenopausal women requiring anticancer gonadotoxic therapy can help clinicians address some challenging issues, including the probability of future pregnancies after the end of treatment. Anti-Müllerian hormone (AMH) and age can reliably estimate ovarian reserve. A limited number of studies have evaluated AMH and age as predictors of residual ovarian reserve following cytotoxic chemotherapy in breast cancer patients. |
Lingua: | Inglese |
Rivista: | |
Citazione: | Barnabei, A., Strigari, L., Marchetti, P., Sini, V., De Vecchis, L., Corsello, S. M., Torino, F., Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram, <<THE ONCOLOGIST>>, 2015; 20 (10): 1111-1118. [doi:10.1634/theoncologist.2015-0183] [http://hdl.handle.net/10807/70223] |
Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |